AI protein specialist Cradle raises US$24m in Series A financing
Generative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led by Index Ventures w
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1118 entries already.
Entries by Thomas Gabrielczyk
Repairing MS-caused damage with stem cells
/in News/by Thomas GabrielczykBritish and Italian researchers have demostrated promising results in patients with progressive multiple sclerosis through stem cell transplantation into the brain.
Novo Nordisk invests €2.1bn in production expansion
/in News/by Thomas GabrielczykIn the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is expanding production in Europe.<br /><br /><br />
Quotient Therapeutics kicks-off with US$50m financing
/in News/by Thomas GabrielczykFlagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.
Solar Foods raises €8m in Series B financing
/in News/by Thomas GabrielczykFinnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
Germany boosts protein transition with €38m
/in News/by Thomas GabrielczykThe Budget Committee of the German Bundestag has announced to channel €38m in funding into the sustainable protein transition next year.<br /><br />
Microharvest GmbH launches SCP-Pilot plant in Lissabon
/in News/by Thomas GabrielczykGerman precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
AMR: Partnership set to improve in vivo antibiotics testing
/in News/by Thomas GabrielczykThe Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing.
VectorY Therapeutics raises €129m in Series A round
/in News/by Thomas Gabrielczyk<p itemprop="headline">Dutch VectorY Tx BV has closed one of this yers’s largest Series A financing rounds in Europe at €129m to push its vecorised antibody pipeline in CNS proteinopathies.</p>
ViaNautis Bio Ltd closes US$25m Series A financing
/in News/by Thomas GabrielczykIntracelluar drug delivery specialist ViaNautis Bio Ltd will use US$25 raised in a Series A financing to push applications of its bionic nanoparticle platform polyNaut.